Capital providers are storming into 2024 with guns blazing, given most fell short of their deployment goals last year. That said, closing a capital raise deal this year will be… Read more »
We’re excited to share our exclusive report to kick off the year: 2023 Healthcare Wrap-Up and Themes to Watch in 2024! Here’s a glimpse of what’s inside: Reflecting on 2023:… Read more »
Intrepid Investment Bankers announced today that it acted as the buy-side advisor to Vivify Specialty Ingredients (“Vivify”), a portfolio company of Gryphon Investors (“Gryphon”), on its acquisition of Access Ingredients… Read more »
Intrepid Investment Bankers (“Intrepid”), a leading middle-market investment bank, announced today that it acted as the buy-side advisor to Russell Reynolds Associates (“RRA”), on its acquisition of Savage Partners. RRA… Read more »
Intrepid Investment Bankers announced today the expansion of its Food, Beverage & Agriculture (FBA) team. Managing Director, Brian Levin, has been named Co-Head of the practice, alongside Managing Director, Mike… Read more »
Intrepid Capital Advisory MARKET MOMENTS THAT MATTER As bargain shoppers seek discounts this holiday season, investors are doing the same in the secondary market. Read more in our latest monthly… Read more »
After showing potential signs of stabilization, the end of Q3 experienced a decline in consumer sentiment, dropping to 63.8 from 67.9 in September. The third quarter also experienced a continued… Read more »
In the words of Mark Twain, “Reports of my death have been greatly exaggerated.” After a year-long slump in the IPO market, a string of recent offerings has provided… Read more »
H1 2023 Update and H2 2023 Outlook In the first half of 2023, global economic uncertainty continued from Q4 2022, as highlighted by the collapse of Silicon Valley Bank, Signature… Read more »